Cancer Patients Who Experience Cognitive Decline After Radiation Treatment for Brain Metastases May Regain Full Neurocognitive Function, New Study Suggests

Nearly 40 percent of cancer patients who experienced memory loss, brain fog and other cognitive difficulties after radiation treatment for brain metastases regained full neurocognitive function within six months, according to a new analysis by radiation oncology researchers at the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC).

Study Finds Disease Progression and Adverse Radiation Effects Are Low in Patients Undergoing Preoperative Stereotactic Radiosurgery

In a new study from Wake Forest University School of Medicine and Atrium Health Levine Cancer Institute, researchers highlight improved outcomes for patients treated with preoperative stereotactic radiosurgery, particularly in rates of tumor recurrence, adverse radiation effects and spread of tumor cells to the fluid outside of the brain.

Stereotactic radiosurgery is effective for treatment of vestibular schwannomas in neurofibromatosis type 2

Vestibular schwannomas related to neurofibromatosis type 2 (NF2) are difficult to manage and are sometimes treated with a noninvasive option, stereotactic radiosurgery. A retrospective study conducted by an international, multicenter team found that stereotactic radiosurgery is effective for patients with these tumors while preserving serviceable hearing and not causing radiation-related tumor development or malignant transformation.